Pharma Marketing Network

OCTOBER 13, 2020

Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?

Physicians 105

Physicians Pharma Pharma reps Pharma Rep 105

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Atrivity

MAY 5, 2021

The days when a pharma rep can walk into any doctors' office at a specific time and expect to see the doctor if they were patient enough, could soon be a distant memory. Those that are able to adapt to the needs of physicians and improve their digital reach will be able to elevate and transform their relationships to another level.

Sales 52

Sales Pharma Doctors Pharma reps 52

Veeva

FEBRUARY 6, 2022

According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1.

Pharma 52

Pharma Medical Consulting Patients 52